Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis

详细信息    查看全文

• 作者：Yanjun Lu ; Wei Liu ; Kun Tan ; Jing Peng ; Yaowu Zhu ; Xiong Wang
• 关键词：CALHM1 ; rs2986017 ; Polymorphism ; Alzheimer’s disease ; Meta ; analysis
• 刊名：Neurological Sciences
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：37
• 期：4
• 页码：525-532
• 全文大小：1,765 KB
• 参考文献：1.Iqbal K, Gong CX, Liu F (2014) Microtubule-associated protein tau as a therapeutic target in Alzheimer’s disease. Expert Opin Ther Targets 18(3):307–318. doi:10.​1517/​14728222.​2014.​870156 CrossRef PubMed
  2.Alzheimer’s A (2014) Alzheimer’s disease facts and figures. Alzheimer’s Dement J Alzheimer’s Assoc 10(2):e47–e92CrossRef
  3.Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, Beecham GW, Smith AV, Chouraki V, Hamilton-Nelson KL, Ikram MA, Fievet N, Denning N, Martin ER, Schmidt H, Kamatani Y, Dunstan ML, Valladares O, Laza AR, Zelenika D, Ramirez A, Foroud TM, Choi SH, Boland A, Becker T, Kukull WA, van der Lee SJ, Pasquier F, Cruchaga C, Beekly D, Fitzpatrick AL, Hanon O, Gill M, Barber R, Gudnason V, Campion D, Love S, Bennett DA, Amin N, Berr C, Tsolaki M, Buxbaum JD, Lopez OL, Deramecourt V, Fox NC, Cantwell LB, Tarraga L, Dufouil C, Hardy J, Crane PK, Eiriksdottir G, Hannequin D, Clarke R, Evans D, Mosley TH Jr, Letenneur L, Brayne C, Maier W, De Jager P, Emilsson V, Dartigues JF, Hampel H, Kamboh MI, Bruijn RF, Tzourio C, Pastor P, Larson EB, Rotter JI, O’Donovan MC, Montine TJ, Nalls MA, Mead S, Reiman EM, Jonsson PV, Holmes C, George-Hyslop PH, Boada M, Passmore P, Wendland JR, Schmidt R, Morgan K, Winslow AR, Powell JF, Carasquillo M, Younkin SG, Jakobsdottir J, Kauwe JS, Wilhelmsen KC, Rujescu D, Nothen MM, Hofman A, Jones L, Consortium I, Haines JL, Psaty BM, Van Broeckhoven C, Holmans P, Launer LJ, Mayeux R, Lathrop M, Goate AM, Escott-Price V, Seshadri S, Pericak-Vance MA, Amouyel P, Williams J, van Duijn CM, Schellenberg GD, Farrer LA (2015) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. doi:10.​1038/​mp.​2015.​23 PubMed
  4.Chouraki V, Seshadri S (2014) Genetics of Alzheimer’s disease. Adv Genet 87:245–294. doi:10.​1016/​B978-0-12-800149-3.​00005-6 CrossRef PubMed
  5.Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Alzheimer Disease Genetics C, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, De Carli C, De Kosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L (2014) Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA neurology 71(11):1394–1404. doi:10.​1001/​jamaneurol.​2014.​1491 CrossRef PubMed PubMedCentral
  6.Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, Marambaud P (2008) A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer’s disease risk. Cell 133(7):1149–1161. doi:10.​1016/​j.​cell.​2008.​05.​048 CrossRef PubMed PubMedCentral
  7.Lambert JC, Sleegers K, Gonzalez-Perez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fievet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsalainen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alperovitch A, Ruiz A, Kamboh MI, Amouyel P (2010) The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer’s disease: a meta-analysis study. J Alzheimer’s Dis 22(1):247–255. doi:10.​3233/​JAD-2010-100933
  8.Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P (2011) CALHM1 P86L polymorphism modulates CSF Abeta levels in cognitively healthy individuals at risk for Alzheimer’s disease. Mol Med 17(9–10):974–979. doi:10.​2119/​molmed.​2011.​00154 PubMed PubMedCentral
  9.Aqdam MJ, Kamali K, Rahgozar M, Ohadi M, Manoochehri M, Tahami A, Bostanshirin L, Khorshid HR (2010) Association of CALHM1 gene polymorphism with late onset Alzheimer’s disease in Iranian population. Avicenna J Med Biotechnol 2(3):153–157PubMed PubMedCentral
  10.Bertram L, Schjeide BM, Hooli B, Mullin K, Hiltunen M, Soininen H, Ingelsson M, Lannfelt L, Blacker D, Tanzi RE (2008) No association between CALHM1 and Alzheimer’s disease risk. Cell 135(6):993–994. doi:10.​1016/​j.​cell.​2008.​11.​030 author reply 994–996 CrossRef PubMed PubMedCentral
  11.Minster RL, Demirci FY, DeKosky ST, Kamboh MI (2009) No association between CALHM1 variation and risk of Alzheimer disease. Hum Mutat 30(4):E566–E569. doi:10.​1002/​humu.​20989 CrossRef PubMed PubMedCentral
  12.Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C (2009) No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Hum Mutat 30(4):E570–E574. doi:10.​1002/​humu.​20990 CrossRef PubMed
  13.Beecham GW, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA (2009) CALHM1 polymorphism is not associated with late-onset Alzheimer disease. Ann Hum Genet 73(Pt 3):379–381CrossRef PubMed PubMedCentral
  14.Lin K, Tang M, Han H, Guo Y, Lin Y, Ma C (2010) Association between the polymorphisms of CALHM1 and GOLPH2 genes and Alzheimer’s disease. Psychiatr Genet 20(4):190. doi:10.​1097/​YPG.​0b013e32833a21cf​ CrossRef PubMed
  15.Cui PJ, Zheng L, Cao L, Wang Y, Deng YL, Wang G, Xu W, Tang HD, Ma JF, Zhang T, Ding JQ, Cheng Q, Chen SD (2010) CALHM1 P86L polymorphism is a risk factor for Alzheimer’s disease in the Chinese population. J Alzheimer’s Dis 19(1):31–35. doi:10.​3233/​JAD-2010-1207
  16.Boada M, Antunez C, Lopez-Arrieta J, Galan JJ, Moron FJ, Hernandez I, Marin J, Martinez-Lage P, Alegret M, Carrasco JM, Moreno C, Real LM, Gonzalez-Perez A, Tarraga L, Ruiz A (2010) CALHM1 P86L polymorphism is associated with late-onset Alzheimer’s disease in a recessive model. J Alzheimer’s Dis 20(1):247–251. doi:10.​3233/​JAD-2010-1357
  17.Nacmias B, Tedde A, Bagnoli S, Lucenteforte E, Cellini E, Piaceri I, Guarnieri BM, Bessi V, Bracco L, Sorbi S (2010) Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer’s disease. J Alzheimer’s Dis 20(1):37–41. doi:10.​3233/​JAD-2010-1345
  18.Tan EK, Ho P, Cheng SY, Yih Y, Li HH, Fook-Chong S, Lee WL, Zhao Y (2011) CALHM1 variant is not associated with Alzheimer’s disease among Asians. Neurobiology of aging 32(3):546 e511-e542. doi:10.​1016/​j.​neurobiolaging.​2009.​05.​008 CrossRef
  19.Feher A, Juhasz A, Rimanoczy A, Pakaski M, Kalman J, Janka Z (2011) No association between CALHM1 polymorphism and Alzheimer’s disease risk in a Hungarian population. Psychiatr Genet 21(5):249–252. doi:10.​1097/​YPG.​0b013e3283457bcc​ CrossRef PubMed
  20.Tao QQ, Sun YM, Liu ZJ, Yang P, Li HL, Lu SJ, Wu ZY (2014) Lack of association between CALHM1 p. P86L variation and Alzheimer’s disease in the Han Chinese population. Neurobiol Aging 35(8):1956 e1913-e1954. doi:10.​1016/​j.​neurobiolaging.​2014.​02.​013
  21.Inoue K, Tanaka N, Yamashita F, Sawano Y, Asada T, Goto Y (2010) The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts. Am J Med Genet Part B Neuropsychiat Genet Off Publ Int Soc Psychiatr Genet 153B(2):532–535. doi:10.​1002/​ajmg.​b.​31014
  22.Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O’Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ (2010) Association of CR1, CLU and PICALM with Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19(16):3295–3301. doi:10.​1093/​hmg/​ddq221 CrossRef PubMed PubMedCentral
  23.Aguilar D, Skrabanek L, Gross SS, Oliva B, Campagne F (2008) Beyond tissueInfo: functional prediction using tissue expression profile similarity searches. Nucleic Acids Res 36(11):3728–3737. doi:10.​1093/​nar/​gkn233 CrossRef PubMed PubMedCentral
  24.Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P (2013) CALHM1 controls the Ca(2)(+)-dependent MEK, ERK, RSK and MSK signaling cascade in neurons. J Cell Sci 126(Pt 5):1199–1206. doi:10.​1242/​jcs.​117135 CrossRef PubMed PubMedCentral
  
• 作者单位：Yanjun Lu (1)
  Wei Liu (2)
  Kun Tan (3)
  Jing Peng (1)
  Yaowu Zhu (1)
  Xiong Wang (1)
  
  1. Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
  2. Department of Public Health, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
  3. Department of Infection Control, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Neurology
  Neuroradiology
  Neurosurgery
  Psychiatry
  
• 出版者：Springer Milan
• ISSN：1590-3478

文摘

Recent studies investigating the association of Calcium homeostasis modulator 1 (CALHM1) p.P86L polymorphism (rs2986017) with Alzheimer’s disease (AD) are controversial. Herein, we performed a meta-analysis to investigate the association between CALHM1 rs2986017 and AD risk. Literature searches of PubMed, Alzgene, and Embase were carried out up to 24 Nov 2015. The strength of the association between rs2986017 and AD was evaluated by odds ratio (OR) and 95 % confidence interval (CI). A total of 19 studies between 2008 and 2014 comprising 8777 AD cases and 8487 controls were included. Significant association of rs2986017 with AD was found in Caucasian population in allelic model (T vs. C: OR 1.13, 95 % CI 1.02–1.26, P = 0.022), and dominant model (TT + TC vs. CC: OR 1.15, 95 % CI 1.04–1.29, P = 0.018). No significant association was found in Asian population in any genetic model. Sensitivity analysis found that Dreses-Werringloer et al.’s might affect the overall result. The current meta-analysis suggested that CALHM1 rs2986017 might be associated with increased AD risk in Caucasian, but not Asian population.